Teva Pharmaceuticals has received approval from the US Food and Drug Administration (FDA) for its supplemental new drug application (sNDA) for three-times-a-week COPAXONE 40mg/mL, a new dose of COPAXONE. COPAXONE (glatiramer acetate ...
The first generic versions of the antidepressant drug Cymbalta (duloxetine delayed-release capsules) have been approved by the U.S. Food and Drug Administration. License to produce generic Cymbalta was granted to Aurobindo Pharma Ltd., ...
Tags: antidepressant drug, Cymbalta, duloxetine delayed-release capsules
Pfizer Inc. announced that it has settled its litigation against Teva Pharmaceuticals, USA Inc., relating to Pfizer's patent covering the use of Viagra? to treat erectile dysfunction (sildenafil citrate 25, 50, and 100 mg tablets), which ...
The U.S. Food and Drug Administration approved the first generic versions of Cymbalta, a drug used to treat depression and other conditions, officials say. Dr. Kathleen Uhl, acting director of the Office of Generic Drugs in the FDA's ...
US-based Biozone Pharmaceuticals has announced that it has agreed to terms and signed a letter of intent (LOI) to merge with Cocrystal Discovery, a privately-held biotechnology company developing antiviral therapeutics for human diseases. ...
Pfizer has reached a $2.15bn settlement with Teva Pharmaceuticals Industries, and Sun Pharmaceutical Industries over Protonix patent-infringement lawsuit in the US. Following 10-years of litigation over the intellectual property for ...
Tags: Pfizer, Sun Pharma
The USFDA has accepted Teva Pharmaceutical Industries' supplemental new drug application (sNDA) for reviewing Copaxone (glatiramer acetate injection) 40mg/1mL. Indicated for patients with relapsing-remitting multiple sclerosis (RRMS), the ...
Tags: Drug Application, Medicine
Mylan Pharmaceuticals has filed suit against FDA seeking to overturn a decision that gives Teva Pharmaceuticals 180-day exclusivity to market the generic version of its affiliate Cephalon's Provigil. Mylan alleges Teva did not keep up ...